We are building:
One platform.
Two levels of insight.
CaniSense Light
CaniSense Light is our fast and affordable first-line cancer screening test for dogs. It is designed primarily for routine check-ups of older or higher-risk dogs, including animals that appear healthy and show no obvious signs of cancer.
Using a simple blood sample, CaniSense Light analyses biological patterns in circulating DNA that may indicate an increased cancer risk. Because it requires less genomic data than our comprehensive test, it can provide results faster and at a lower cost.
The goal is to help answer an important first question:
“Does this dog show a cancer-related signal that should be investigated further?”
CaniSense Light does not aim to determine the exact cancer type. Instead, it provides an accessible first step that can help veterinarians decide whether additional investigation is appropriate. It can also support repeated, tumour-agnostic monitoring when changes over time are more important than identifying a specific tumour type.
CaniSense
CaniSense provides a deeper and more comprehensive analysis. It examines more information from the DNA fragments circulating in the dog's blood and combines these signals using bioinformatics and AI.
Cancer can leave measurable changes in circulating DNA. CaniSense is designed to recognise several of these signals together, helping veterinarians assess whether cancer may be present and providing more detailed information to support cancer classification and further diagnostic decisions.
The result is delivered as a veterinary report and is intended to complement—not replace—the clinical examination, medical history, imaging, pathology and other diagnostic information available to the veterinarian.
In simple terms:
CaniSense Light asks: “Is there a cancer-related signal we should investigate?”
CaniSense asks: “What more can we learn about that signal?”
From Screening to Monitoring: Different Use Cases
The CaniSense platform is designed to support veterinarians at different stages of the cancer-care journey.
1. Cancer Screening
For older and higher-risk dogs that do not yet show obvious symptoms, CaniSense Light can be incorporated into routine health checks as an additional screening tool.
Its purpose is to identify cancer-related signals early and help veterinarians recognise patients that may benefit from closer examination or further diagnostics.
For veterinary practices, this creates the opportunity to introduce preventive cancer screening as a new clinical service alongside regular senior-dog check-ups.
2. Diagnostic Support
When cancer is already suspected—for example because of symptoms, examination findings or abnormal imaging—CaniSense provides a more detailed molecular assessment.
By analysing multiple cancer-related patterns in circulating DNA, CaniSense can provide an additional layer of information that helps the veterinarian evaluate the overall clinical picture and decide on appropriate next diagnostic steps.
The goal is not to replace established diagnostics, but to increase the information available for clinical decision-making while enabling practices to offer a more advanced diagnostic service.
3. Tumor and Treatment Monitoring
Cancer care does not end with diagnosis. Changes in cancer-related signals in the blood can also provide useful information over time.
CaniSense Light and CaniSense can support longitudinal monitoring, depending on the level of information required. Repeated testing may help veterinarians follow changes during treatment, investigate possible residual disease or recurrence, and decide when additional diagnostic evaluation may be appropriate.
For veterinary practices, longitudinal testing also creates a more continuous relationship with the patient throughout treatment and follow-up care.
One platform across the cancer-care journey
Together, CaniSense Light and CaniSense are designed to provide different levels of information for different clinical situations:
Screen earlier → investigate further → monitor over time.
This allows veterinarians to choose the appropriate level of testing according to the patient's situation—from a healthy senior dog undergoing routine screening, to a patient with suspected cancer, to a dog already receiving treatment.
The result is a flexible platform that connects cancer screening, diagnostic support and ongoing monitoring in one blood-based workflow.